About DAWN2
DAWN2™: a response to challenges and opportunities
Although it has been almost ten years since the original DAWN™ study, and in spite of considerable efforts to improve diabetes care over that decade, many people with diabetes still face significant challenges in areas including self-management, adherence, access to support and involvement in care. Many also face the challenges of clinical inertia and poorly structured primary care.
All this at the same time that IT – especially the internet and social media – are opening up unprecedented opportunities for social support and empowerment.
A network of international experts and organisations, in partnership with and supported by Novo Nordisk, responded to these challenges and opportunities by initiating the DAWN2™ study in 2011. The study builds on the experience gained by researchers in the behavioural and psychological sciences since the first DAWN™ study in 2001. The result is the first multinational study to give a holistic view of care in diabetes as it covers all the key people involved, including patient associations, people with diabetes, their family members and healthcare professionals. The study also covers policy experts in a scientific policy research arm that focuses on education and psychosocial support.
A global view
With insights gained from more than 15,000 people across 17 countries, DAWN2™ is even more extensive in scope than the first DAWN™ study. And the holistic approach of DAWN2™ means that this global view is also a 360° view, including the views of family members and other stakeholders not previously included in similar studies.
DAWN2™ key objectives
A 360° view and global approach have been adopted to help the DAWN2™ study meet its key objectives:
- Advance the understanding and awareness of the unmet needs of people with diabetes and their caregivers, and how they have evolved over the last decade
- Facilitate broad, early and ongoing dialogue and collaboration with key stakeholders to improve patient involvement, self-management and psychosocial support.
- Facilitate scientific patient-oriented monitoring, benchmarking and sharing of better practices at policy, healthcare and individual levels to ultimately stimulate improvements in outcomes.
